Literature DB >> 11028559

Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival.

V E Strong1, P J Mackrell, E M Concannon, H A Naama, P A Schaefer, G W Shaftan, P P Stapleton, J M Daly.   

Abstract

Major injury leads to impaired immune responses and increases the risk of infectious complications. Following trauma, increased prostaglandin E2 (PGE2) levels may be important in immunodysregulation. We hypothesized that blocking PGE2 with NS-398, a selective COX-2 inhibitor, during the first 24 h after injury may modify the immune response and protect the host from a subsequent septic challenge. BALB/c mice were given NS-398 (10 mg/kg) immediately after injury, at 12, and at 24 h after sham injury or trauma (femur fracture and 40% hemorrhage). On day 7 after injury, splenic macrophages were evaluated for cytokine production and COX-2 mRNA. In a separate study mice were injured, then given 3 doses of NS-398. After 7 days, cecal ligation and puncture was performed and mice were followed for survival. Traumatized mice given NS-398 had a significant survival advantage compared with trauma mice alone (P < 0.001). Macrophages from traumatized mice showed increased COX-2 mRNA and proinflammatory cytokines compared with controls (P < 0.05), whereas treatment of injured mice with NS-398 significantly decreased proinflammatory cytokine production (P < 0.05) and COX-2 mRNA. Therefore NS-398 given within 24 h of injury suppressed PGE2 through inhibition of cyclooxygenase, in addition to decreasing proinflammatory cytokines, and providing a survival advantage to the host.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028559     DOI: 10.1097/00024382-200014030-00023

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  11 in total

Review 1.  Eicosanoid regulation of pulmonary innate immunity post-hematopoietic stem cell transplantation.

Authors:  Megan N Ballinger; Tracy R McMillan; Bethany B Moore
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Jan-Feb       Impact factor: 4.291

2.  Aging and estrogen: modulation of inflammatory responses after injury.

Authors:  Christian R Gomez; Timothy P Plackett; Elizabeth J Kovacs
Journal:  Exp Gerontol       Date:  2007-01-03       Impact factor: 4.032

Review 3.  Targeting the "cytokine storm" for therapeutic benefit.

Authors:  Riccardo V D'Elia; Kate Harrison; Petra C Oyston; Roman A Lukaszewski; Graeme C Clark
Journal:  Clin Vaccine Immunol       Date:  2013-01-02

4.  Inhibition of inflammatory responses by FC-77, a perfluorochemical, in lipopolysaccharide-treated RAW 264.7 macrophages.

Authors:  Hung Chang; Fu-Chang Kuo; Yuan-Shu Lai; Tz-Chong Chou
Journal:  Intensive Care Med       Date:  2005-06-02       Impact factor: 17.440

5.  Concentrations of PGE2 and TXB2 in the Eyes of Mice with Disseminated Acanthamoebiasis.

Authors:  Karolina Kot; Daria Kołodziej; Patrycja Kupnicka; Danuta Izabela Kosik-Bogacka; Natalia Łanocha-Arendarczyk
Journal:  Pathogens       Date:  2022-04-04

6.  Lipopolysaccharide desensitizes monocytes-macrophages to CD40 ligand stimulation.

Authors:  Anna Sinistro; Chiara Ciaprini; Silvia Natoli; Emanuele Sussarello; Francesca Calò Carducci; Cristiana Almerighi; Marcella Capozzi; Francesca Bolacchi; Giovanni Rocchi; Alberto Bergamini
Journal:  Immunology       Date:  2007-06-29       Impact factor: 7.397

Review 7.  Cyclooxygenase inhibition in sepsis: is there life after death?

Authors:  David M Aronoff
Journal:  Mediators Inflamm       Date:  2012-05-14       Impact factor: 4.711

8.  Effects of lornoxicam on the physiology of severe sepsis.

Authors:  Dilek Memiş; Beyhan Karamanlioğlu; Alparslan Turan; Onur Koyuncu; Zafer Pamukçu
Journal:  Crit Care       Date:  2004-10-27       Impact factor: 9.097

9.  EP2 Receptor Blockade Attenuates COX-2 Upregulation During Intestinal Inflammation.

Authors:  Jamie Golden; Laura Illingworth; Patil Kavarian; Oswaldo Escobar; Patrick Delaplain; Mubina Isani; Jin Wang; Joanna Lim; Jordan Bowling; Brandon Bell; Christopher P Gayer; Anatoly Grishin; Henri R Ford
Journal:  Shock       Date:  2020-09       Impact factor: 3.533

Review 10.  Lipid mediators in immune dysfunction after severe inflammation.

Authors:  James N Fullerton; Alastair J O'Brien; Derek W Gilroy
Journal:  Trends Immunol       Date:  2013-11-21       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.